Christopher Martenson

Christopher Hamlin Martenson
Born	15 September 1962 (1962-09-15) (age 49)
Nationality	USA
Known for	Former Vice President of Pfizer, Inc. and Science Applications International Corporation

Christopher Martenson, PhD, is an American scientist who has done research in biochemistry, neurotoxicology, applied pharmacology and in vitro techniques.^{[citation needed]} He received his doctorate in neurotoxicology at Duke University in 1994 with his thesis Acrylamide neurotoxicity: effect on neuronal growth cones and axonal fast transport, and completed a post-doctoral programme at that university in 1995–1997 where he specialised in neuronal signal transduction and transport^{[citation needed]}. Martenson also holds an MBA degree from Cornell University (1998) and is a fellow of the Post Carbon Institute.^[1]

Career

Christopher Martenson was Consultant In Business Development and Strategies at Pfizer, Inc.^{[citation needed]} Later he became the Vice President of the company,^{[citation needed]} and later still – a Vice President of Science Applications International Corporation's Life Sciences Division,^[2] which position he held till July 2005.

In more recent years Martenson stepped away from biological sciences and management to develop an educational video seminar series called The Crash Course (originally published in October 2008) based on neo-malthusian concepts. The course investigates the ways in which the economy, the environment and energy are interlinked and interact.^{[citation needed]}

Publications

1. Axonal transport: beyond kinesin and cytoplasmic dynein, Current opinion in neurobiology, 1991–Oct, vol. 1 (issue 3): pp. 393–398
2. Fast axonal transport is required for growth cone advance, Nature, 366, 66–69 (4 November 1993)
3. Acrylamide neurotoxicity: effect on neuronal growth cones and axonal fast transport, a Duke University thesis, Ph.D. M377A 1994 LSC.
4. In Vitro Acrylamide exposure alters growth cone morphology, Toxicology and Applied Pharmacology, Volume 131, Issue 1, March 1995, pp. 119–129
5. The effect of acrylamide and other sulfhydryl alkylators on the ability of Dynein and Kinesin to translocate microtubules in Vitro, Toxicology and Applied Pharmacology, Volume 133, Issue 1, July 1995, pp. 73–81
6. Calmodulin dynamics within intact hippocampal cells, Duke University, 1F32NS010263-01 (1996)
7. Inhibition of Lyn function in mast cell activation by SH3 domain binding peptides, Biochemistry, 1997, 36 (31), pp. 9388–9394
8. Internal trafficking and surface mobility of a functionally intact beta 2-adrenergic receptor – green fluorescent protein conjugate, Molecular Pharmacology, 51:177–184 (1997)
9. Cornell equity research of ArQule, Inc., Cornell University, 17 November 1997

References

1. ^ Fellow biographies, Post Carbon Institute
2. ^ SAIC chooses Arcot for strong authentication, Marketwire, June 2003

Persondata
Name	Martenson, Christopher
Alternative names
Short description
Date of birth	15 September 1962
Place of birth
Date of death
Place of death